It has been shown in studies19-20 that NF-κB mediated signaling pathway is associated with radiation resistance characteristics and adverse clinical outcomes in a variety of cancers, and reducing the expression of NF-κB and its downstream genes EGFR, COX-2, and VEGF is contribute to improving radiotherapy sensitivity. This evidence concerns the gene NFKB1 and cancer.